[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355800-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355800-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","overall-survival-outcomes-in-occult-primary-breast-cancer-article-overview","Overall survival outcomes in occult primary breast cancer - Article overview","","Counseling patients with occult primary breast cancer (OPBC) is difficult because of its rarity and limited oncologic outcome data. This study evaluates management and overall survival (OS) for OPBC versus primary breast tumors using National Cancer Database patients (2010–2021). OS is estimated with Kaplan–Meier and analyzed with multivariable Cox models. Results show favorable OPBC outcomes similar to cT1N+ across nodal categories, with older age, higher clinical N category, Charlson Deyo comorbidity score, non-white race, and triple-negative biology linked to worse OS.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/overall-survival-outcomes-in-occult-primary-breast-cancer-article-overview/355800/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/overall-survival-outcomes-in-occult-primary-breast-cancer-article-overview/355800.png","ImageObject",300,407,{"name":42,"@type":43},"Stanford","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is occult primary breast cancer (OPBC) in clinical terms?","Question",{"text":63,"@type":64},"OPBC is defined by axillary metastases from breast origin without a clinically identifiable primary breast lesion.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were overall survival (OS) outcomes analyzed in the study?",{"text":68,"@type":64},"OS was assessed using Kaplan–Meier methods and multivariable Cox proportional hazards models.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were associated with worse overall survival within OPBC?",{"text":72,"@type":64},"Increasing age, triple-negative tumor biology, and increasing nodal category were associated with worse survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355800,1790536060,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","The Breast 88 (2026) 104798  \nContents lists available at ScienceDirect  \nThe Breast  \njournal [homepage:](homepage: www.journals.elsevier.com/the-breast)[ www.journals.elsevier.com/the-breast](homepage: www.journals.elsevier.com/the-breast)  \n| Overall survival outcomes in occult primary breast cancer Nara L. Tashjiana, Courtney Day b, Judy C. Bougheya, Mara A. Piltinc,* \u003Cbr>a Division of Breast and Melanoma Surgical Oncology, Department of Surgery, Mayo Clinic, Rochester, MN, USA b Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USAc Division of Surgical Oncology, Department of Surgery, Mayo Clinic, Jacksonville, FL, USA |  |  | |\n| --- | --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Occult breast cancer\u003Cbr>Overall survival\u003Cbr>Axillary lymph node dissection |  | Background: Counseling patients with occult primary breast cancer (OPBC) can be challenging due its infrequency and the paucity of oncologic outcomes data. We aimed to evaluate the management and overall survival (OS) of patients with OPBC compared to patients with primary breast tumors.\u003Cbr>Methods: We identified patients with node positive breast cancer from the National Cancer Database (2010- 2021). OPBC was classified at cT0. OS was assessed using Kaplan-Meier method and multivariable Cox proportional hazards models.\u003Cbr>Results: Of 254,708 patients with cT0-4N1-3 disease, 2680 patients with OPBC were identified (cT0N1 63.4%, cT0N2 72.5%, cT0N3 80.7%). Five-year OS for cT0N1 (88.5%) was most similar to cT1N1 disease (88.2%) and better than cT2-4N1. On multivariable analysis, cT1-4N1 had significantly worse survival than cT0N1 (HR: 1.30- 3.84, each p \u003C 0.001). Patients with cT0N2 disease had similar 5-year OS to cT1N2, both 83.4%. Similarly, patients with cT0N2 had improved survival compared to patients with cT2-4N2 (HR: 1.62-3.02, each p \u003C 0.001). In cN3 patients, OS of OPBC was 72.8% vs 73.9% for cT1, 73.3% for cT2, 67.2% cT3, and 52.6% cT4. Within OPBC, increasing age (HR 1.64, p \u003C 0.001), triple negative biology (HR 1.27, p = 0.0499) and increasing nodal category were associated with worse survival.\u003Cbr>Conclusions: Outcome for OPBC is favorable and is similar to cT1N + disease across all cN categories. Factors that impact OS included older age, increasing clinical N category, worse Charlson Deyo Comorbidity Score, non-white race and triple negative tumor biology. |  |\n\n1. Introduction  \nOccult primary breast cancer (OPBC) is a rare clinical presentation defined by the presence of axillary metastases from breast origin in the absence of a clinically identifiable primary breast lesion. This clinical scenario accounts for less than 1% of breast cancer diagnoses [1]. Current management recommendations include imaging evaluation, systemic therapy, axillary surgery±breast surgery and radiation therapy [2].  \nBreast magnetic resonance imaging (MRI) is currently the standard of care in evaluating a patient presenting with OPBC. MRI is significantly more sensitive than mammography and in the normal screening population has been found to identify 8-13% more cancers that are mammographically occult [3]. MRI performs better in detection of small cancers and evaluation of patients with dense breast tissue due to it being both anatomic and functional imaging [4]. A meta-analysis of patients with axillary metastasis with no identifiable primary tumor on  \nmammogram or ultrasound and found that between 36 and 86% of patients had a primary breast cancer ultimately detected with MRI [5]. For these reasons, it is an important step prior to assigning the diagnosis of OPBC and has been recommended in the NCCN guidelines.  \nHistorically, mastectomy and axillary lymph node dissection (ALND) were the standard treatment for patients with OPBC, however, multiple studies have failed to demonstrate an OS benefit to mastectomy over whole breast radiation alone [6], [7], [8]. Thus, axi","cbCaisoHjiJDwlkz","https://ap.wps.com/l/cbCaisoHjiJDwlkz","pdf",3602538,"English","# Introduction\n## Occult primary breast cancer definition and clinical context\n## Imaging role of breast MRI\n## Historical and evolving management strategies\n# Methods\n## Patient cohort\n## Statistical analysis approach\n# Results\n## Survival comparisons and multivariable findings\n# Conclusions","[{\"question\":\"What is occult primary breast cancer (OPBC) in clinical terms?\",\"answer\":\"OPBC is defined by axillary metastases from breast origin without a clinically identifiable primary breast lesion.\"},{\"question\":\"How were overall survival (OS) outcomes analyzed in the study?\",\"answer\":\"OS was assessed using Kaplan–Meier methods and multivariable Cox proportional hazards models.\"},{\"question\":\"Which factors were associated with worse overall survival within OPBC?\",\"answer\":\"Increasing age, triple-negative tumor biology, and increasing nodal category were associated with worse survival.\"}]","Overall survival outcomes in occult primary breast cancer - Article overview | PDF",1790121041,18,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e0c4bae648e7401739c6ce768b5a79c.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d250ee2c17860628a15377c75a11713.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6501554086bb23d13c3076b2d08da64.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4af27aa2d02cba509ecc59d29c667d6.webp",980,1306]